Literature DB >> 9736104

Outbreak of pneumonia in a long-term care facility: antecedent human parainfluenza virus 1 infection may predispose to bacterial pneumonia.

A E Fiore1, C Iverson, T Messmer, D Erdman, S M Lett, D F Talkington, L J Anderson, B Fields, G M Carlone, R F Breiman, M S Cetron.   

Abstract

OBJECTIVES: To determine the causes of an outbreak of lobar pneumonia.
DESIGN: Matched (1:2) case-control study.
SETTING: A 70-bed chronic care facility for older people. PARTICIPANTS: Residents of the facility.
RESULTS: Ten residents developed pneumonia over a 10-day period. Two residents died. One case-patient had Streptococcus pneumoniae bacteremia; another had polymerase chain reaction evidence of S. pneumoniae infection. No other etiologic agent was identified. Only four of 10 case-patients had received routine diagnostic cultures of blood or sputum before the administration of antibiotics. Symptoms of upper respiratory illness (URI) among residents before the pneumonia outbreak corresponded with elevation of antibodies to human parainfluenza virus 1 (HPIV1). In a matched case-control study, six of 10 case-patients, compared with five of 20 controls, had symptoms of URI during the preceding month (matched odds ratio (MOR) = 4.5, 95% CI = 0.8-33). Nine case-patients had serum available, and five of these had both serologic evidence of recent HPIV1 infection and recent URI, compared with two of 18 controls (MOR = 9.0, 95% CI = 1.2-208). Only three residents had documentation of pneumococcal vaccination.
CONCLUSIONS: Noninfluenza viral infections may play a role in the pathogenesis of some bacterial pneumonias. S. pneumoniae was the cause of at least two pneumonias; lack of preantibiotic cultures may have interfered with isolation of S. pneumoniae in others. Recent HPIV1 infection was epidemiologically linked to subsequently developing pneumonia. Spread of HPIV1 in the facility may have contributed to increased susceptibility to S. pneumoniae and, potentially, to other bacterial pathogens.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9736104     DOI: 10.1111/j.1532-5415.1998.tb06649.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  16 in total

1.  Codon substitution mutations at two positions in the L polymerase protein of human parainfluenza virus type 1 yield viruses with a spectrum of attenuation in vivo and increased phenotypic stability in vitro.

Authors:  Josephine M McAuliffe; Sonja R Surman; Jason T Newman; Jeffrey M Riggs; Peter L Collins; Brian R Murphy; Mario H Skiadopoulos
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

2.  Human parainfluenza virus 4 outbreak and the role of diagnostic tests.

Authors:  Susanna K P Lau; Wing-Kin To; Philomena W T Tse; Alex K H Chan; Patrick C Y Woo; Hoi-Wah Tsoi; Annie F Y Leung; Kenneth S M Li; Paul K S Chan; Wilina W L Lim; Raymond W H Yung; Kwok-Hung Chan; Kwok-Yung Yuen
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

Review 3.  Epidemiology of pneumococcal infections in the elderly.

Authors:  J C Butler; A Schuchat
Journal:  Drugs Aging       Date:  1999       Impact factor: 3.923

Review 4.  Parainfluenza viruses.

Authors:  Kelly J Henrickson
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

5.  Generation of recombinant human parainfluenza virus type 1 vaccine candidates by importation of temperature-sensitive and attenuating mutations from heterologous paramyxoviruses.

Authors:  Jason T Newman; Jeffrey M Riggs; Sonja R Surman; Josephine M McAuliffe; Teresa A Mulaikal; Peter L Collins; Brian R Murphy; Mario H Skiadopoulos
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

6.  Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection.

Authors:  Angela J Peck; Janet A Englund; Jane Kuypers; Katherine A Guthrie; Lawrence Corey; Rhoda Morrow; Robert C Hackman; Anne Cent; Michael Boeckh
Journal:  Blood       Date:  2007-05-14       Impact factor: 22.113

7.  Community-based outbreaks in vulnerable populations of invasive infections caused by Streptococcus pneumoniae serotypes 5 and 8 in Calgary, Canada.

Authors:  Otto G Vanderkooi; Deirdre L Church; Judy MacDonald; Franziska Zucol; James D Kellner
Journal:  PLoS One       Date:  2011-12-27       Impact factor: 3.240

8.  An explosive outbreak of Streptococcus pneumoniae serotype-8 infection in a highly vaccinated residential care home, England, summer 2012.

Authors:  H L Thomas; R Gajraj; M P E Slack; C Sheppard; P Hawkey; S Gossain; C M Drew; R G Pebody
Journal:  Epidemiol Infect       Date:  2014-10-09       Impact factor: 4.434

9.  The Enduring Challenge of Determining Pneumonia Etiology in Children: Considerations for Future Research Priorities.

Authors:  Daniel R Feikin; Laura L Hammitt; David R Murdoch; Katherine L O'Brien; J Anthony G Scott
Journal:  Clin Infect Dis       Date:  2017-06-15       Impact factor: 9.079

Review 10.  Respiratory Syncytial Virus and Other Noninfluenza Respiratory Viruses in Older Adults.

Authors:  Fumihiro Kodama; David A Nace; Robin L P Jump
Journal:  Infect Dis Clin North Am       Date:  2017-12       Impact factor: 5.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.